SDBN Presents: aTyr Pharma on Reaching Beyond In Vitro Drug Discovery

The San Diego Biotechnology Network hosts aTyr Pharma, with CEO Jeffry Watkins giving a talk on “Innovation: Where is our Biology?” aTyr is developing therapeutics based on physiocrines, small proteins involved in signaling pathways for areas such hematology, immunology, and metabolism disorders. More information and online registration can be found here.